Presentation ESC 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

REGISTER for free or LOG IN to view this content

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Heart Failure

Heart Failure Pharma

Presentation

ESC 2019

PARAGON-HF

HFpEF

Up Next

Presentation

test 2 slide - server migration

September 09, 2000

More slides +

Presentation TCT 2019

It Is All About the Data! Importance of Digital Intelligence in the Development of Useful Predictive Models

Presenter: Campbell Rogers

September 25, 2019

Presentation TCT 2019

Session I: Challenges and Opportunities in MedTech Innovation - Health Care Disparity: An Emerging Opportunity for MedTech Innovation

Presenter: Ian Meredith

September 25, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.